Real time insider trading transaction history:
- Insiders are prohibited from making short-swing profits by trading their shares within 6 months of the registration or acquiring the shares.
- Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
Common stock purchase or sale:
Transaction Date | Reported DateTime | Company | Symbol | Insider Relationship | Shares Traded | Average Price | Total Amount | Shares Owned | Filing |
2024-06-14 Sale | 2024-06-17 7:03 pm | Aileron Therapeutics Inc. | ALRN | UNIVERSITY OF TEXAS/TEXAS AM INVESTMENT MANAGEMENT CO 10% Owner | 6,607 | $3.2644 | $21,568 | 1,746,549 (Direct) | View |
2024-06-10 Sale | 2024-06-12 6:18 pm | Aileron Therapeutics Inc. | ALRN | UNIVERSITY OF TEXAS/TEXAS AM INVESTMENT MANAGEMENT CO 10% Owner | 24,671 | $3.2714 | $80,710 | 1,753,156 (Direct) | View |
2024-06-05 Sale | 2024-06-07 6:59 pm | Aileron Therapeutics Inc. | ALRN | UNIVERSITY OF TEXAS/TEXAS AM INVESTMENT MANAGEMENT CO 10% Owner | 12,315 | $3.291 | $40,528 | 1,777,827 (Direct) | View |
2024-05-01 Sale(A) | 2024-05-14 5:54 pm | Aileron Therapeutics Inc. | ALRN | UNIVERSITY OF TEXAS/TEXAS AM INVESTMENT MANAGEMENT CO 10% Owner | 20,315 | $4.2074 | $85,473 | 1,790,142 (Direct) | View |
2024-04-29 Sale | 2024-05-01 7:15 pm | Aileron Therapeutics Inc. | ALRN | UNIVERSITY OF TEXAS/TEXAS AM INVESTMENT MANAGEMENT CO 10% Owner | 31,151 | $4.4654 | $139,103 | 1,779,306 (Direct) | View |
2023-12-15 Purchase | 2023-12-18 5:56 pm | AILERON THERAPEUTICS INC | ALRN | WINDSOR JAMES BRIAN President and COO | 225 | $3.37 | $758 | 5,347 (Indirect Direct) | View |
2023-11-20 Purchase | 2023-11-21 4:43 pm | AILERON THERAPEUTICS INC | ALRN | WINDSOR JAMES BRIAN President and COO | 5,076 | $1.9675 | $9,987 | 5,122 (Direct) | View |
Stock options: Exercise, Award, Grant, Conversion
Transaction Date | Reported DateTime | Exercisable Expiration | Company | Symnbol | Insider Relationship | Shares Traded | Conversion Price | Shares Owned | Filing |
2024-08-20 Option Award | 2024-08-22 4:09 pm | N/A 2034-08-19 | Aileron Therapeutics Inc. | ALRN | Aivado Manuel Director | 2,725 | $0 | 2,725 (Direct) | View |
2024-08-20 Option Award | 2024-08-22 4:07 pm | N/A 2034-08-19 | Aileron Therapeutics Inc. | ALRN | VON RICKENBACH JOSEF H Director | 2,725 | $0 | 2,725 (Direct) | View |
2024-08-20 Option Award | 2024-08-22 4:06 pm | N/A 2034-08-19 | Aileron Therapeutics Inc. | ALRN | Fairey William Director | 2,725 | $0 | 2,725 (Direct) | View |
2024-08-20 Option Award | 2024-08-22 4:06 pm | N/A 2034-08-19 | Aileron Therapeutics Inc. | ALRN | Ambros Reinhard J. Director | 2,725 | $0 | 2,725 (Direct) | View |
2024-08-20 Option Award | 2024-08-22 4:05 pm | N/A 2034-08-19 | Aileron Therapeutics Inc. | ALRN | Musso Alan A Director | 2,725 | $0 | 2,725 (Direct) | View |
Ownership | 2024-04-30 3:32 pm | N/A N/A | Aileron Therapeutics Inc. | ALRN | UNIVERSITY OF TEXAS/TEXAS AM INVESTMENT MANAGEMENT CO 10% Owner | 0 | $0 | 1,812,627 (Direct) | View |
2024-02-28 Option Award(A) | 2024-04-10 4:15 pm | N/A 2034-02-27 | Aileron Therapeutics Inc. | ALRN | VON RICKENBACH JOSEF H Director | 2,725 | $0 | 2,725 (Direct) | View |
2024-02-28 Option Award(A) | 2024-04-10 4:15 pm | N/A 2034-02-27 | Aileron Therapeutics Inc. | ALRN | Ambros Reinhard J. Director | 2,725 | $0 | 2,725 (Direct) | View |
Ownership | 2024-04-02 6:10 pm | N/A 2030-03-31 | Aileron Therapeutics Inc. | ALRN | Garner Charles Senior Vice President, Finance | 0 | $0 | 375,347 (Direct) | View |
2024-03-05 Exercise | 2024-03-06 5:06 pm | N/A N/A | AILERON THERAPEUTICS INC | ALRN | WINDSOR JAMES BRIAN President and COO | 2,002 | $0 | 7,347 (Direct) | View |
2024-02-28 Option Award | 2024-03-01 4:05 pm | N/A 2034-02-27 | AILERON THERAPEUTICS INC | ALRN | Ambros Reinhard J. Director | 2,725 | $0 | 2,725 (Direct) | View |
2024-02-28 Option Award | 2024-03-01 4:05 pm | N/A 2034-02-27 | AILERON THERAPEUTICS INC | ALRN | VON RICKENBACH JOSEF H Director | 2,725 | $0 | 2,725 (Direct) | View |
2023-10-31 Option Award | 2023-11-02 8:55 pm | N/A 2033-10-30 | AILERON THERAPEUTICS INC | ALRN | Fairey William Director | 5,450 | $0 | 5,450 (Direct) | View |
2023-10-31 Option Award | 2023-11-02 8:53 pm | N/A 2033-10-30 | AILERON THERAPEUTICS INC | ALRN | Musso Alan A Director | 5,450 | $0 | 5,450 (Direct) | View |
Ownership | 2023-11-02 8:51 pm | N/A 2032-05-08 | AILERON THERAPEUTICS INC | ALRN | Musso Alan A Director | 0 | $0 | 17,064 (Direct) | View |
Ownership | 2023-11-02 8:50 pm | N/A 2031-11-16 | AILERON THERAPEUTICS INC | ALRN | Fairey William Director | 0 | $0 | 17,064 (Direct) | View |
Ownership | 2023-11-02 8:47 pm | N/A N/A | AILERON THERAPEUTICS INC | ALRN | WINDSOR JAMES BRIAN See Remarks | 0 | $0 | 926,834 (Direct) | View |
2022-06-15 Option Award | 2022-06-17 5:22 pm | N/A 2032-06-14 | AILERON THERAPEUTICS INC | ALRN | Morrison Jodie Pope Director | 54,500 | $0 | 54,500 (Direct) | View |
2022-06-15 Option Award | 2022-06-17 5:18 pm | N/A 2032-06-14 | AILERON THERAPEUTICS INC | ALRN | MCKEE WILLIAM Director | 54,500 | $0 | 54,500 (Direct) | View |
2022-06-15 Option Award | 2022-06-17 5:16 pm | N/A 2032-06-14 | AILERON THERAPEUTICS INC | ALRN | VON RICKENBACH JOSEF H Director | 54,500 | $0 | 54,500 (Direct) | View |
2022-06-15 Option Award | 2022-06-17 5:12 pm | N/A 2032-06-14 | AILERON THERAPEUTICS INC | ALRN | Sigal Nolan Howard Director | 54,500 | $0 | 54,500 (Direct) | View |
2022-06-15 Option Award | 2022-06-17 5:12 pm | N/A 2032-06-14 | AILERON THERAPEUTICS INC | ALRN | Ambros Reinhard J. Director | 54,500 | $0 | 54,500 (Direct) | View |
2022-06-15 Option Award | 2022-06-17 5:10 pm | N/A 2032-06-14 | AILERON THERAPEUTICS INC | ALRN | Bailey Jeffrey Allen Director | 54,500 | $0 | 54,500 (Direct) | View |
2022-03-30 Option Award(A) | 2022-03-30 8:33 pm | N/A 2032-03-29 | AILERON THERAPEUTICS INC | ALRN | Aivado Manuel See Remarks | 1,133,000 | $0 | 1,133,000 (Direct) | View |
2022-03-30 Option Award(A) | 2022-03-30 8:32 pm | N/A 2032-03-29 | AILERON THERAPEUTICS INC | ALRN | Vukovic Vojo Chief Medical Officer | 150,000 | $0 | 150,000 (Direct) | View |
2022-03-30 Option Award(A) | 2022-03-30 8:32 pm | N/A 2032-03-29 | AILERON THERAPEUTICS INC | ALRN | Wanstall Rick See Remarks | 393,000 | $0 | 393,000 (Direct) | View |
2022-03-30 Option Award(A) | 2022-03-30 8:31 pm | N/A 2032-03-29 | AILERON THERAPEUTICS INC | ALRN | Annis Allen SVP, Research | 313,000 | $0 | 313,000 (Direct) | View |
2022-03-22 Option Award | 2022-03-24 7:45 pm | N/A 2032-03-21 | AILERON THERAPEUTICS INC | ALRN | Wanstall Rick See Remarks | 393,000 | $0 | 393,000 (Direct) | View |
2022-03-22 Option Award | 2022-03-24 7:45 pm | N/A 2032-03-21 | AILERON THERAPEUTICS INC | ALRN | Annis Allen SVP, Research | 313,000 | $0 | 313,000 (Direct) | View |
2022-03-22 Option Award | 2022-03-24 7:44 pm | N/A 2032-03-21 | AILERON THERAPEUTICS INC | ALRN | Aivado Manuel See Remarks | 1,133,000 | $0 | 1,133,000 (Direct) | View |
2022-03-22 Option Award | 2022-03-24 7:43 pm | N/A 2032-03-21 | AILERON THERAPEUTICS INC | ALRN | Vukovic Vojo Chief Medical Officer | 150,000 | $0 | 150,000 (Direct) | View |